Clinical Trial

Clinical Study of AFN50 Injection in the Autoimmune Diseases

Name: Clinical Study of AFN50 Injection in the Autoimmune Diseases — clinical trial record (NCT07408336)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is an investigator-initiated trial designed to evaluate the safety, tolerability and primary efficacy of AFN50 injection for the treatment of autoimmune diseases.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-10.

Status change: Not Yet Recruiting → Recruiting 2026-03-03

Trial Details

NCT Number	NCT07408336
Lead Sponsor	AlphaNa Bioscience Company Limited Collaborators: The First Affiliated Hospital of Anhui Medical University
Conditions	Autoimmune Diseases
Enrollment	18 participants
Start Date	2026-02-04
Primary Completion	2028-02-04 (estimated)
Study Completion	2029-02-03 (estimated)
Updated on ClinicalTrials.gov	2026-03-05